Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Lymphoma
Lymphoma
Immunotherapy with PD-1 Inhibitors the Newest Breakthrough in Hodgkin Lymphoma
Wayne Kuznar
Read More
Lymphoma
Rituximab Maintenance Extends Remission in Follicular Lymphoma, but Overall Survival Unaffected
Caroline Helwick
Read More
Lymphoma
Surveillance Scanning in Transformed Indolent Lymphoma of Limited Clinical Benefit
Wayne Kuznar
Read More
Lymphoma
PI3K Inhibitors Main Focus of Drug Pipeline for Lymphoma
Caroline Helwick
Read More
Lymphoma
Bendamustine plus Rituximab Noninferior to Standard Chemotherapy for Indolent Non-Hodgkin and Mantle-Cell Lymphomas
Caroline Helwick
Read More
Lymphoma
PET-Directed Approach to Treating Early-Stage Hodgkin Lymphoma Produces Excellent Outcomes
Wayne Kuznar
Read More
Lymphoma
Ara-C Should Be Part of Conditioning Regimen in Young Patients with Mantle-Cell Lymphoma
Audrey Andrews
Read More
Lymphoma
Optimal Length of Treatment of Non-Hodgkin Lymphoma Debated
Caroline Helwick
Read More
Lymphoma
HBV Screening before Lymphoma Treatment Improves Outcomes, Is Cost-Effective
Read More
1
2
3
Page 3 of 3
Results 21 - 29 of 29